Tramutola A, Arena A, Cini C, et al
Ethics declarations Conflict of interest All authors declare that they have no competing interest in this article
Molecular neurobiology, 52(2), 826836
No surprise fees
ZEPBOUND- tirzepatide injection, solution, Eli Lilly and Company (2025) Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: The SURMOUNT-3 phase 3 trial, Nature Medicine (2023) Adverse events related to tirzepatide, Journal of the Endocrine Society (2023) Symptoms of low blood sugar, Kaiser Permanente (2025) How Zepbound works, Eli Lilly (2025) Dehydration, MedlinePlus (2023) Continued treatment with tirzepatide for maintenance of weight reduction in adults with obesity: The SURMOUNT-4 randomized clinical trial, JAMA (2023) Eight Symptoms of Type 2 Diabetes, Kaiser Permanente (2025) Electrolytes, Cleveland Clinic (2021) Bad headache
Some patients use Ipamorelin for 3-6 month cycles with breaks, while others incorporate it into longer-term protocols